Evidence map›Paper›PMID 34787065›Full record

ArticleGut microbes

The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids.

Amrita Vijay, Afroditi Kouraki, Sameer Gohir, James Turnbull, Anthony Kelly, Vicky Chapman, David A Barrett, William J Bulsiewicz, Ana M Valdes

Open access · goldAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Amrita VijayDivision of Rheumatology, Orthopedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0002-9595-5680
Afroditi KourakiDivision of Rheumatology, Orthopedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Sameer GohirDivision of Rheumatology, Orthopedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
James TurnbullNihr Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK.
Anthony KellyDivision of Rheumatology, Orthopedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Vicky ChapmanDivision of Rheumatology, Orthopedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
David A BarrettNihr Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK.
William J BulsiewiczLowcountry Gastroenterology Associates, Mount Pleasant, South Caroline, USA.
Ana M ValdesDivision of Rheumatology, Orthopedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0003-1141-4471
University of Nottingham · GBUniversity Surgical Associates · US

Funding

Department of HealthMedical Research Council MR/V027883/1Versus Arthritis 20777
6 · The paper itself

Abstract

The endocannabinoid (EC) system has pleiotropic functions in the body. It plays a key role in energy homeostasis and the development of metabolic disorders being a mediator in the relationship between the gut microbiota and host metabolism. In the current study we explore the functional interactions between the endocannabinoid system and the gut microbiome in modulating inflammatory markers. Using data from a 6 week exercise intervention (treatment n = 38 control n = 40) and a cross sectional validation cohort (n = 35), we measured the associations of 2-arachidonoylglycerol (2-AG), anandamide (AEA),

Indexed as

Anti-Inflammatory AgentsBacteriaCohort StudiesCross-Sectional StudiesEndocannabinoidsFatty Acids, VolatileFemaleGastrointestinal MicrobiomeHumansImmune SystemInterleukin-6Longitudinal StudiesMaleMiddle AgedAnti-Inflammatory AgentsEndocannabinoidsFatty Acids, VolatileInterleukin-6Endocannabinoidsexercisegut microbesinflammatory markersinterventionSCFA

Identifiers

PMID34787065
PMCPMC8604388
OpenAlexW3212121879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.